data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

ADMA Biologics Inc

(NASDAQ:ADMA)

Perks Buy Compare Brokers

$3.81

0.11[2.97%]

Last update: 4:20PM (Delayed 15-Minutes)
Get Real Time Here

$3.81

0[0.00%]

After-Hours

Perks Buy Compare Brokers

Open3.700	Close3.810
Vol / Avg.1.719M / 1.915M	Mkt Cap860.937M
Day Range3.640 - 3.830	52 Wk Range2.945 - 4.650

0

Latest News for ADMA Biologics Stock (NASDAQ:ADMA)

ADMA Biologics Stock (NASDAQ: ADMA)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, November 17, 2023

HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $5 Price Target
Benzinga Newsdesk - Nov 17, 2023, 7:14AM

Thursday, November 16, 2023

ADMA Biologics Has Received FDA Approval For Its Tenth ADMA BioCenters Plasma Collection Facility In Laurel, Maryland. This Plasma Collection Facility Commenced Operations And Initiated Source Plasma Collection In 1H Of 2023
Benzinga Newsdesk - Nov 16, 2023, 7:05AM

Thursday, November 09, 2023

ADMA Biologics shares are trading higher after the company reported better-than-expected Q3 financial results.
Benzinga Newsdesk - Nov 9, 2023, 9:13AM

Wednesday, November 08, 2023

ADMA Biologics Increases FY25 Revenue Exceeds $335M
Benzinga Newsdesk - Nov 8, 2023, 5:35PM
ADMA Biologics Increases FY24 Revenue Exceeds $290M Vs $278.4M Est.
Benzinga Newsdesk - Nov 8, 2023, 5:34PM
ADMA Biologics Increases FY23 Revenue Exceeds $250M Vs $243.06M Est.
Benzinga Newsdesk - Nov 8, 2023, 5:33PM
ADMA Biologics shares are trading higher after the company reported better-than-expected Q3 financial results.
Benzinga Newsdesk - Nov 8, 2023, 4:42PM
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Nov 8, 2023, 4:31PM
ADMA Biologics Q3 EPS $0.01 Beats $(0.01) Estimate, Sales $67.28M Beat $62.12M Estimate
Benzinga Newsdesk - Nov 8, 2023, 4:30PM
Earnings Scheduled For November 8, 2023
Benzinga Insights - Nov 8, 2023, 4:21AM

Tuesday, November 07, 2023

Earnings Preview: ADMA Biologics
Benzinga Insights - Nov 7, 2023, 11:01AM

Thursday, August 31, 2023

ADMA Biologics shares are trading higher following the purchase of 130K shares by a company director.
Bill Haddad - Aug 31, 2023, 10:28AM

Friday, August 18, 2023

Massive Insider Trade At ADMA Biologics
Benzinga Insights - Aug 18, 2023, 11:01AM
ADMA Biologics EVP Acquires 809,262 Shares After Exercising Company Stock Options
Benzinga Insights - Aug 18, 2023, 11:00AM

Thursday, August 10, 2023

Cantor Fitzgerald Maintains Overweight on ADMA Biologics, Raises Price Target to $6
Benzinga Newsdesk - Aug 10, 2023, 12:58PM
ADMA Biologics shares are trading higher after the company raised its FY23 revenue outlook.
Benzinga Newsdesk - Aug 10, 2023, 12:54PM
Raymond James Maintains Strong Buy on ADMA Biologics, Raises Price Target to $6
Benzinga Newsdesk - Aug 10, 2023, 9:34AM
HC Wainwright & Co. Maintains Buy on ADMA Biologics, Raises Price Target to $5
Benzinga Newsdesk - Aug 10, 2023, 7:48AM

Wednesday, August 09, 2023

ADMA Biologics Raises FY23 Revenue $240M Vs $226.03M Est
Benzinga Newsdesk - Aug 9, 2023, 5:43PM
ADMA Biologics Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $60.12M Beat $55.50M Estimate
Benzinga Newsdesk - Aug 9, 2023, 4:24PM
Earnings Scheduled For August 9, 2023
Benzinga Insights - Aug 9, 2023, 4:54AM

Tuesday, August 08, 2023

Preview: ADMA Biologics's Earnings
Benzinga Insights - Aug 8, 2023, 11:01AM

Wednesday, July 19, 2023

ADMA Biologics shares are trading higher after the company announced it received U.S. Food and Drug Administration approval for its ADMA BioCenters plasma collection facility.
Benzinga Newsdesk - Jul 19, 2023, 11:15AM
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
Lisa Levin - Jul 19, 2023, 10:23AM
The FDA Has Approved ADMA Biologics' Ninth ADMA Biocentres Plasma Collection Facility Located In Dallas, GA; The Plasma Collection Facility Commenced Operations And Initiated Source Plasma Collection In Q3 2022
Benzinga Newsdesk - Jul 19, 2023, 7:05AM

Thursday, May 11, 2023

ADMA Biologics shares are trading higher after the company reported better-than-expected Q1 financial results.
Benzinga Newsdesk - May 11, 2023, 8:50AM

Wednesday, May 10, 2023

Recap: ADMA Biologics Q1 Earnings
Benzinga Insights - May 10, 2023, 5:10PM
ADMA Biologics Q1 EPS $(0.03) Beats $(0.04) Estimate, Sales $56.91M Beat $53.41M Estimate
Happy Mohamed - May 10, 2023, 4:09PM
Earnings Scheduled For May 10, 2023
Benzinga Insights - May 10, 2023, 9:12AM

Tuesday, May 09, 2023

A Preview Of ADMA Biologics's Earnings
Benzinga Insights - May 9, 2023, 11:02AM

Monday, March 27, 2023

HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $4.5 Price Target
Benzinga Newsdesk - Mar 27, 2023, 6:13AM

Friday, March 24, 2023

Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin - Mar 24, 2023, 1:03PM
ADMA Biologics, C3.ai And Other Big Stocks Moving Higher On Friday
Lisa Levin - Mar 24, 2023, 10:59AM
ADMA Biologics Earnings Perspective: Return On Capital Employed
Benzinga Insights - Mar 24, 2023, 10:47AM
Dow Down 150 Points; US Durable Goods Orders Drop In February
Lisa Levin - Mar 24, 2023, 9:47AM
ADMA Biologics shares are trading higher after the company reported better-than-expected Q4 sales results and issued FY23 revenue guidance above estimates.
Benzinga Newsdesk - Mar 24, 2023, 8:36AM
Oxford Industries, Express And 3 Stocks To Watch Heading Into Friday
Lisa Levin - Mar 24, 2023, 4:00AM

Thursday, March 23, 2023

ADMA Biologics Sees FY23 Revenue $210M Vs $202.75M Est
Benzinga Newsdesk - Mar 23, 2023, 4:36PM
UPDATE: ADMA Biologics Q4 EPS $(0.06), Inline, Sales $49.95M Beat $45.93M Estimate
Benzinga Newsdesk - Mar 23, 2023, 4:31PM
After-Hours Action: Why ADMA Biologics Shares Are Trading Higher
Adam Eckert - Mar 23, 2023, 4:29PM
ADMA Biologics Q4 EPS $(0.06), Inline
Benzinga Newsdesk - Mar 23, 2023, 4:16PM
Earnings Scheduled For March 23, 2023
Benzinga Insights - Mar 23, 2023, 8:10AM

Wednesday, March 22, 2023

Earnings Outlook For ADMA Biologics
Benzinga Insights - Mar 22, 2023, 12:02PM

Thursday, March 09, 2023

EVP at ADMA Biologics Acquires Company Stock Options Worth 270,345 Shares
Benzinga Insights - Mar 9, 2023, 10:01AM
ADMA Biologics President and CEO Awarded $3.94M Worth of Stock Options
Benzinga Insights - Mar 9, 2023, 10:01AM

Wednesday, February 08, 2023

HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $4.5 Price Target
Benzinga Newsdesk - Feb 8, 2023, 12:20PM
ADMA BioCenters Receives FDA Approval For Eighth Plasma Collection Center
Bill Haddad - Feb 8, 2023, 7:00AM

Tuesday, January 17, 2023

ADMA Biologics Sees Prelim. Q4 Revenues $49M-$50M vs $43.75M Est., Sees Prelim. FY22 Revenue $153M-$154M vs $148.95M Est.
Benzinga Newsdesk - Jan 17, 2023, 7:07AM

Tuesday, January 10, 2023

Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better
Lisa Levin - Jan 10, 2023, 8:24AM

Tuesday, January 03, 2023

HC Wainwright & Co. Maintains Buy on ADMA Biologics, Raises Price Target to $4.5
Benzinga Newsdesk - Jan 3, 2023, 6:14AM

1
2
3
4
5
6
7
Next
17

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2023 Benzinga | All Rights Reserved